Home › Stock analysis › MRKR
Marker Therapeutics (MRKR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $0.92, +3.37% vs the prior close of $0.89.
- Volume 120.20K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MRKR jumps 3.4% to $0.92. Closed at $0.92, +3.37% vs the prior close of $0.89. Day range $0.88–$0.96, opened at $0.96.
Last close$0.92+3.37%
Day range0.88–0.96
Open0.96
Volume120.20K
52-week range0.84–2.46
Avg volume (20d)85.64K
MRKR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MRKR jumps 3.4% to $0.92
- Closed at $0.92, +3.37% vs the prior close of $0.89. Day range $0.88–$0.96, opened at $0.96.
- Volume was 120.20K shares, 1.5x its 50-day average of 77.75K.
- Price is -21.5% vs its 50-day average ($1.17) and -34.8% vs its 200-day average ($1.41).
- 52-week range $0.84–$2.46; today's close sits at 5% of that range, 62.6% below the 52-week high.
Oct 14, 2026 — MRKR slides 3.3% to $0.89, a 6-month low
- Closed at $0.89, -3.26% vs the prior close of $0.92. Day range $0.89–$0.95, opened at $0.92.
- Volume was 65.80K shares, 0.9x its 50-day average of 77.11K.
- Price is -24.3% vs its 50-day average ($1.18) and -37.0% vs its 200-day average ($1.41).
- 52-week range $0.84–$2.46; today's close sits at 3% of that range, 63.8% below the 52-week high.
Oct 13, 2026 — MRKR slides 8.9% to $0.92, a 6-month low on 2.3x normal volume
- Closed at $0.92, -8.91% vs the prior close of $1.01. Day range $0.91–$1.03, opened at $1.03.
- Volume was 175.20K shares, 2.3x its 50-day average of 74.91K — unusually heavy trading.
- Price is -22.2% vs its 50-day average ($1.18) and -35.0% vs its 200-day average ($1.42).
- 52-week range $0.84–$2.46; today's close sits at 5% of that range, 62.6% below the 52-week high.
Oct 12, 2026 — MRKR jumps 4.1% to $1.01
- Closed at $1.01, +4.12% vs the prior close of $0.97. Day range $0.98–$1.03, opened at $0.98.
- Volume was 107.80K shares, 1.5x its 50-day average of 73.51K.
- Price is -15.0% vs its 50-day average ($1.19) and -28.8% vs its 200-day average ($1.42).
- 52-week range $0.84–$2.46; today's close sits at 10% of that range, 58.9% below the 52-week high.
Oct 9, 2026 — MRKR rises 2.1% to $0.97
- Closed at $0.97, +2.11% vs the prior close of $0.95. Day range $0.93–$1.00, opened at $0.93.
- Volume was 91.20K shares, 1.2x its 50-day average of 73.14K.
- Price is -18.6% vs its 50-day average ($1.19) and -31.7% vs its 200-day average ($1.42).
- 52-week range $0.84–$2.46; today's close sits at 8% of that range, 60.6% below the 52-week high.
Oct 8, 2026 — MRKR slides 8.7% to $0.95, a 6-month low
- Closed at $0.95, -8.65% vs the prior close of $1.04. Day range $0.95–$1.05, opened at $1.04.
- Volume was 96.90K shares, 1.3x its 50-day average of 71.99K.
- Price is -20.4% vs its 50-day average ($1.19) and -33.2% vs its 200-day average ($1.42).
- 52-week range $0.84–$2.46; today's close sits at 7% of that range, 61.4% below the 52-week high.
Oct 7, 2026 — MRKR rises 3.0% to $1.04
- Closed at $1.04, +2.97% vs the prior close of $1.01. Day range $1.03–$1.06, opened at $1.03.
- Volume was 37.50K shares, 0.5x its 50-day average of 71.64K — lighter than usual.
- Price is -13.1% vs its 50-day average ($1.20) and -27.0% vs its 200-day average ($1.42).
- 52-week range $0.84–$2.46; today's close sits at 12% of that range, 57.7% below the 52-week high.
Oct 6, 2026 — MRKR slides 4.7% to $1.01, a 6-month low
- Closed at $1.01, -4.72% vs the prior close of $1.06. Day range $1.00–$1.07, opened at $1.07.
- Volume was 77.10K shares, 1.1x its 50-day average of 70.94K.
- Price is -15.8% vs its 50-day average ($1.20) and -29.1% vs its 200-day average ($1.43).
- 52-week range $0.84–$2.46; today's close sits at 10% of that range, 58.9% below the 52-week high.
Oct 5, 2026 — MRKR rises 1.0% to $1.06
- Closed at $1.06, +0.95% vs the prior close of $1.05. Day range $1.05–$1.09, opened at $1.08.
- Volume was 73.50K shares, 1.0x its 50-day average of 70.63K.
- Price is -12.0% vs its 50-day average ($1.20) and -25.7% vs its 200-day average ($1.43).
- 52-week range $0.84–$2.46; today's close sits at 14% of that range, 56.9% below the 52-week high.
Oct 2, 2026 — MRKR ends flat (+0.0%) to $1.05, 7 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.02–$1.08, opened at $1.06.
- Volume was 100.30K shares, 1.5x its 50-day average of 68.91K.
- Price is -13.1% vs its 50-day average ($1.21) and -26.4% vs its 200-day average ($1.43).
- 52-week range $0.84–$2.46; today's close sits at 13% of that range, 57.3% below the 52-week high.
- That makes 7 straight losses.
MRKR latest news & SEC filings
Every SEC filing by or about MRKR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.83M (prior year -$4.02M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.09 (prior year -$0.29) (loss narrowed vs Jun 30, 2025)
Things to know before you trade MRKR
- Last results release: Mar 19, 2026 (8-K Item 2.02). Previous ones: Nov 14, 2025, Mar 31, 2025, Nov 14, 2024. Based on that rhythm, the next report is likely around Jun 18, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.02% (largest 8.9%). That is a volatile stock.
- Liquidity: about 85.64K shares (≈$78.79K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.92 vs a range of $0.84–$2.46 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 10-Q May 15, 2026; 8-K May 4, 2026.
- Share count: 16.67M shares outstanding (Aug 7, 2026), +28.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MRKR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.96 | 0.96 | 0.88 | 0.92 | 120.20K |
| Oct 14, 2026 | 0.92 | 0.95 | 0.89 | 0.89 | 65.80K |
| Oct 13, 2026 | 1.03 | 1.03 | 0.91 | 0.92 | 175.20K |
| Oct 12, 2026 | 0.98 | 1.03 | 0.98 | 1.01 | 107.80K |
| Oct 9, 2026 | 0.93 | 1.00 | 0.93 | 0.97 | 91.20K |
| Oct 8, 2026 | 1.04 | 1.05 | 0.95 | 0.95 | 96.90K |
| Oct 7, 2026 | 1.03 | 1.06 | 1.03 | 1.04 | 37.50K |
| Oct 6, 2026 | 1.07 | 1.07 | 1.00 | 1.01 | 77.10K |
| Oct 5, 2026 | 1.08 | 1.09 | 1.05 | 1.06 | 73.50K |
| Oct 2, 2026 | 1.06 | 1.08 | 1.02 | 1.05 | 100.30K |
| Oct 1, 2026 | 1.08 | 1.09 | 0.98 | 1.05 | 127.50K |
| Sep 30, 2026 | 1.12 | 1.14 | 1.07 | 1.07 | 38.40K |
| Sep 29, 2026 | 1.14 | 1.16 | 1.08 | 1.10 | 90.90K |
| Sep 28, 2026 | 1.12 | 1.15 | 1.07 | 1.13 | 164.30K |
| Sep 25, 2026 | 1.22 | 1.22 | 1.15 | 1.15 | 29.60K |
| Sep 24, 2026 | 1.26 | 1.31 | 1.15 | 1.19 | 141.60K |
| Sep 23, 2026 | 1.24 | 1.27 | 1.23 | 1.24 | 64.90K |
| Sep 22, 2026 | 1.18 | 1.24 | 1.18 | 1.22 | 38.70K |
| Sep 21, 2026 | 1.18 | 1.22 | 1.18 | 1.20 | 24.20K |
| Sep 18, 2026 | 1.19 | 1.23 | 1.17 | 1.18 | 47.30K |
About Marker Therapeutics
Marker Therapeutics (MRKR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HOUSTON, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1094038.
MRKR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kathryn Penkus Corzo | Director | Nov 4, 2025 |
| Steve Elms | Director | Nov 19, 2025 |
| Norman David Eansor | Director | Nov 19, 2025 |
| Katharine Knobil | Director | Nov 19, 2025 |
| Juan Vera | Chief Executive Officer | Nov 4, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Juan Vera | Chief Executive Officer | Nov 4, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MRKR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-12.16M | -0.79 | $-12.01M |
| Dec 31, 2024 | — | $-10.73M | -1.19 | $-10.91M |
| Dec 31, 2023 | — | $-8.24M | -0.94 | $-16.44M |
| Dec 31, 2022 | — | $-29.93M | -3.58 | $-26.97M |
| Dec 31, 2021 | $0 | $-41.88M | -5.47 | $-27.28M |
Latest balance sheet: total assets $14.59M, total liabilities $2.42M, cash $11.33M (as of Jun 30, 2026).
MRKR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 19, 2026 | 8-K Item 2.02 (results) | $1.32 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $0.92 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $1.23 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.50 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 26, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
| Mar 22, 2023 | 8-K Item 2.02 (results) | — |
| Nov 10, 2022 | 8-K Item 2.02 (results) | — |
| Aug 11, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MRKR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.